Turner Christopher Durant (CIK 1862146) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-07). Recent activity: Sell NUVL (871 shares), Sell NUVL (1,119 shares), Sell NUVL (1,929 shares), Sell NUVL (317 shares), Sell NUVL (1,321 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 871 | $83,668 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 1,119 | $108,375 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 1,929 | $188,965 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 317 | $31,231 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 1,321 | $127,807 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 1,635 | $159,135 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Sell | 225 | $22,140 |
| 2026-01-07 | Nuvalent, Inc. (NUVL) | Chief Medical Officer | Buy | 17,500 | $0 |
Source: SEC Form 4 filings · as of 2026-01-07